Deep Dive into China’s GBA Access for Drugs and Devices
Venue:
Start: Tuesday 03 Sept 2024 10:00
End: Tuesday 03 Sept 2024 11:00
This webinar is brought to you by ABHI member, Cisema.
Are you looking to navigate the complexities of China’s Greater Bay Area (GBA) regulatory pathways for your pharmaceutical or medical device company?
Join us on Tuesday, September 3rd, 2024 for a focused 1-hour webinar that will provide you with the insights needed to leverage the GBA pathway effectively.
Webinar Highlights:
- Discover how Hong Kong is positioned as a critical gateway for international companies looking to enter the GBA market, with insights from Andy Wong of InvestHK.
- Dr Grace Lau from the Institute for Translational Research will share insights into key projects supported by HKSTP, including collaborations with leading global MedTech firms such as AstraZeneca, Boehringer Ingelheim and Roche.
- Case Studies & Regulatory Reform: Understand the '+1' Mechanism with practical examples, get updated on newly streamlined regulations, and see how companies are successfully navigating the GBA landscape.
Speakers:
- Jacky Li, Regulatory Lead Hong Kong, Cisema
- Dr Grace Lau - Head of Institute for Translational Research, HKSTP
- Andy Wong - Head of Innovation and Technology, InvestHK
- Anthony Barker, Sales Director, Cisema